Retatrutide 20mg (R&D Only)

135.00

 

 

Product Overview – Technical Specifications

Parameter Value
Product Name Retatrutide 20mg
Also Known As LY3437943
CAS Number 2381089-83-2
Molecular Formula C221H342N46O68
Molecular Weight 4731.33 g/mol
Purity >99% by HPLC
Appearance White lyophilized powder
Test Methods HPLC, Mass Spectrometry
Endotoxin Level <1.0 EU/mg
Residual Solvents Meets ICH guidelines

 

Description

 Buy Retatrutide 20mg (R&D Only) – Research Peptide For Sale

Retatrutide 20mg is a research-grade triple agonist peptide designed for preclinical metabolic research applications. As a GLP-1, GIP, and glucagon receptor co-agonist, this compound enables sophisticated in vitro and in vivo studies of integrated metabolic pathways. Each vial contains 20mg of lyophilized peptide with verified purity through independent HPLC/MS analysis. Buy retatrutide-20mg-rd-only Peptides EU

This product is strictly for research use only and is not intended for human consumption. For researchers seeking to buy peptides EU with documented quality assurance, Retatrutide 20mg represents a significant advancement in multi-target receptor pharmacology research. Buy retatrutide-20mg-rd-only Peptides EU

Visit our homepage at euresearchpeptides.com to explore our complete range of research chemicals EU compliant products.

Sequence Information

Retatrutide is a fatty acid acylated single peptide chain engineered for triple receptor activation. The sequence incorporates modifications for enhanced stability and extended half-life in research models.


Triple Agonist Mechanism of Action

Retatrutide represents a paradigm shift in multi-targeted peptide research. Unlike single or dual agonists, this compound activates three distinct receptors :

Receptor Binding Profile

Target Receptor EC50 Value
GIPR (Glucose-dependent Insulinotropic Polypeptide Receptor) 0.0643 nM
GLP-1R (Glucagon-like Peptide-1 Receptor) 0.775 nM
GCGR (Glucagon Receptor) 5.79 nM

This triple agonism profile enables researchers to study the synergistic effects of simultaneous pathway activation, an area of growing interest in metabolic disease research. A 2025 publication in Clinical and Molecular Hepatology notes that multi-agonist incretin-based therapies represent a paradigm shift in metabolic research .


Purity Specifications & Quality Assurance

Every batch of Retatrutide 20mg undergoes rigorous independent testing:

  • HPLC Purity: >99% as determined by reverse-phase HPLC

  • Mass Spectrometry: Confirmed molecular weight within ±0.05%

  • Peptide Content: Net peptide weight verified

  • Water Content: <5% by Karl Fischer

  • Acetate Content: <12% by ion chromatography

  • Bacterial Endotoxins: <1.0 EU/mg

  • Sterility: Negative for microbial growth

Each shipment includes a Certificate of Analysis (COA) from an independent EU laboratory. For researchers requiring high purity peptides Germany standards, our Retatrutide meets or exceeds industry specifications.


Solubility Profile

Retatrutide solubility varies by solvent system. Based on published data:

Solvent Solubility Notes
Water 20 mg/mL Adjust pH to 9 with aqueous NH3, ultrasonic assistance
DMSO 50-100 mg/mL Ultrasonic assistance recommended
CMC-Na (5mg/mL) Homogeneous suspension For in vivo research applications
Ethanol Insoluble Not recommended

Recommended Reconstitution Protocol for Research

  1. Preparation – Allow the sealed vial to reach room temperature (15-25°C) before opening to prevent condensation.

  2. Solvent Selection – For most in vitro applications, sterile bacteriostatic water or sterile saline is appropriate. For challenging solubility, dilute DMSO stock in aqueous buffer.

  3. pH Consideration – Retatrutide solubility is enhanced at pH 9.0. Use dilute NH3 or NaOH for adjustment.

  4. Gentle Mixing – Add solvent slowly down the inner vial wall. Swirl gently. Do not vortex or shake vigorously.

  5. Visual Inspection – Ensure complete dissolution before use. Solution should be clear and particle-free.


Stability Data & Storage Conditions

Storage Recommendations

Condition Lyophilized Powder Reconstituted Solution
-80°C (Ultra-low freezer) 24+ months 6 months
-20°C (Standard freezer) 12-24 months 1 month
2-8°C (Refrigeration) 12 months 7-14 days
15-25°C (Room temperature) 30 days (stable for shipping) 8-12 hours

Critical Stability Notes

  • Retatrutide degrades at temperatures above 25°C within 48 hours

  • Protect from light exposure during handling and storage

  • Keep vials sealed and away from moisture

  • Nitrogen purging recommended for long-term storage

  • Avoid repeated freeze-thaw cycles for reconstituted solutions

  • The product can be shipped at room temperature without compromising powder stability for up to one month

For researchers conducting laboratory peptides Netherlands studies, proper storage protocol compliance ensures experimental reproducibility.


Known Research Applications

Retatrutide is an investigational triple agonist peptide studied in preclinical models for metabolic research applications.

Primary Research Areas

1. Metabolic Energy Homeostasis
Preclinical studies indicate that triple GLP-1/GIP/glucagon agonism may increase energy expenditure and fat oxidation compared to single or dual agonists. Researchers investigating GLP-1 research peptides EU applications find Retatrutide valuable for comparative pathway studies.

2. Appetite Regulation Signaling
The GLP-1 component of Retatrutide activates satiety signaling pathways in validated research models. This makes the compound relevant for studies examining central and peripheral appetite regulation mechanisms.

3. Glucose Homeostasis Markers
Preclinical research describes effects on insulin release markers and glucose homeostasis. Triple agonism may offer distinct advantages over GLP-1 monotherapy in glucose regulation studies.

4. Lipid Metabolism and Fatty Acid Oxidation
Glucagon receptor activation is associated with increased fatty acid oxidation and alterations in lipid profiles in research settings. Retatrutide enables simultaneous study of these pathways.

5. Hepatic Research Applications
Published literature suggests potential applications in studies of metabolic dysfunction-associated steatotic liver disease (MASLD) and hepatic lipid metabolism.

Citation Note

The above applications are derived from preclinical studies and published literature. These are not health claims but rather descriptions of ongoing research areas. For researchers seeking peptides for research France or peptide supplier Spain products, Retatrutide offers a unique triple agonist tool.


Proper Handling Protocols

Required Safety Equipment

  • Powder-free nitrile gloves

  • Safety goggles

  • Laboratory coat

  • Biosafety cabinet for reconstitution

Handling Precautions for Research Chemicals EU Compliant Use

  1. Vial Inspection – Before opening, inspect for any damage to the crimp seal or stopper. Do not use if compromised.

  2. Surface Decontamination – Wipe the rubber stopper with a 70% alcohol pad before piercing.

  3. Aseptic Technique – Maintain sterile conditions throughout handling. Work in a biosafety cabinet when possible.

  4. Avoid Contamination – Use separate sterile needles/syringes for each vial. Never re-enter a vial with a used needle.

  5. Venting – When adding diluent, inject air equal to the volume of liquid to be withdrawn to prevent vacuum formation.

Reconstitution Guidelines for Retatrutide 20mg

Example Calculation for 1mg/mL Concentration:

  • Add 20mL bacteriostatic water to 20mg vial

  • Final concentration: 1mg/mL

Example Calculation for 2mg/mL Concentration:

  • Add 10mL bacteriostatic water to 20mg vial

  • Final concentration: 2mg/mL

For Research Administration Protocols:
Based on published research protocols, typical dosing in preclinical models ranges from 0.25mg to 1mg administered twice weekly. For research SARMs and peptide combination studies, concentration calculations must be verified before use.


Safety Considerations

Regulatory Status

As of 2025, Retatrutide is not approved by the FDA, EMA, or any other regulatory agency for human therapeutic use. It remains an investigational compound in late-stage clinical trials.

Important Safety Information for Buy Peptides EU Customers

  • For laboratory research use only

  • Not for human or veterinary consumption

  • Not for diagnostic or therapeutic applications

  • Must be clearly labeled Research Use Only (RUO) in any downstream distribution

  • Purchasers must be qualified researchers affiliated with recognized institutions

Disposal Guidelines

  • Unused peptide: Decontaminate with 10% bleach solution before disposal

  • Empty vials: Autoclave or chemically decontaminate

  • Needles and syringes: Sharps container

  • Follow local and institutional regulations for chemical waste disposal


Why Choose Euresearchpeptides.com

As a premium UE-based online retailer specializing in buy peptides EU, we provide:

  • EU Warehouse Stock – Fast shipping across Germany, France, Netherlands, Spain, Italy, Belgium, Austria, Switzerland, Sweden, Denmark, and all EU member states

  • Verified Purity – Every batch includes Certificate of Analysis with HPLC/MS data from independent EU laboratories

  • EU Regulatory Compliance – Full adherence to REACH, GHS labeling, and research chemical regulations

  • Cold Chain Shipping – Temperature-controlled packaging for peptide integrity

  • Research Documentation – Complete documentation including COA, SDS, and RUO labeling

  • Dedicated Support – Expert assistance for reconstitution and protocol questions

For peptide synthesis Europe and BPC-157 Europe research needs, trust Euresearchpeptides.com as your reliable partner.


SEO FAQ Section – High Commercial Intent

Q1: Where can I buy Retatrutide 20mg for research in Europe?

You can purchase Retatrutide 20mg directly from euresearchpeptides.com, a trusted buy peptides EU supplier. We maintain EU warehouse stock for fast delivery across Germany, France, Netherlands, Spain, and all EU countries. Order Retatrutide 20mg now

Q2: What is the purity of your Retatrutide 20mg?

Our Retatrutide 20mg is tested at >99% purity by HPLC with mass spectrometry confirmation. Each batch includes an independent Certificate of Analysis. This meets the highest high purity peptides Germany standards. View COA

Q3: How should I reconstitute Retatrutide 20mg for research?

Reconstitute Retatrutide 20mg with sterile bacteriostatic water or sterile saline. For challenging solubility, dilute DMSO stock in aqueous buffer. Adjust pH to 9.0 for optimal solubility. Always use aseptic technique. For peptides for research France protocols, follow your institutional guidelines. Reconstitution guide

Q4: What is the molecular weight of Retatrutide?

Retatrutide has a molecular formula of C221H342N46O68 and molecular weight of 4731.33 g/mol . CAS number is 2381089-83-2.

Q5: How should I store Retatrutide 20mg?

Store lyophilized Retatrutide at -20°C for long-term storage (12-24 months) or 2-8°C for short-term use (up to 12 months). Reconstituted solutions should be used within 7-14 days when refrigerated. For laboratory peptides Netherlands studies, follow strict temperature control. Storage instructions

Q6: Is Retatrutide legal to buy for research in the EU?

Yes, Retatrutide can be legally purchased for legitimate research purposes when sourced from a compliant supplier with proper RUO labeling and documentation. Euresearchpeptides.com provides full research chemicals EU compliant documentation including COA, SDS, and RUO labeling. Check compliance

Q7: What receptors does Retatrutide target?

Retatrutide is a triple agonist targeting three receptors: GLP-1 receptor, GIP receptor, and glucagon receptor (GCGR) . This triple agonism distinguishes it from dual agonists like Tirzepatide.

Q8: Do you ship Retatrutide 20mg to my country?

We ship Retatrutide 20mg to all EU member states including Germany, France, Netherlands, Spain, Italy, Belgium, Austria, Switzerland, Sweden, Denmark, Finland, Norway, and more as a leading peptide supplier Spain and European distributor. Check shipping

Q9: What documentation comes with Retatrutide 20mg?

Each order includes Certificate of Analysis (COA), Safety Data Sheet (SDS), and RUO labeling on all packaging. Invoice clearly states For Research Use Only . For BPC-157 Europe and other peptide research supplies, full documentation is standard.

Q10: Can I use Retatrutide 20mg with other research peptides?

Researchers may study Retatrutide in combination with other compounds depending on their specific research objectives. Always verify compatibility and stability for your specific application. For research SARMs and combination studies, consult relevant literature. Contact our team


Related Products from Euresearchpeptides.com

Researchers who purchase Retatrutide 20mg often also buy:

  • Research Spray Add-on Kit – Complete reconstitution and administration toolkit

  • Bacteriostatic Water – Sterile diluent for peptide reconstitution

  • Sterile Empty Vials – For mixing and storage of reconstituted solutions

  • Insulin Syringes – For precise research administration

Reviews

There are no reviews yet.

Be the first to review “Retatrutide 20mg (R&D Only)”

Your email address will not be published. Required fields are marked *